Life Science Barometer

A facts-based snapshot of the Swedish life science sector enabling informed business decisions and a stronger industry.

The Life Science Barometer is a yearly survey of the Swedish life science-industry that generates an up-to-date overview of Swedish life science and highlights needs and trends in the industry.

Presenting the theme of the 2022 report with key data and the theme for the 2023 report. Click here to open the infographic as a PDF.

The 2023 survey

The 2023 Life Science Barometer was produced by SwedenBIO in cooperation with STUNS, Stockholm Science City, Medicon Village and Sahlgrenska Science Park.

List of companies that filled out the 2023 survey (contains only names of companies which opted to be announced).

ZelmicMedeon Science Park & IncubatorArex AdvisorOncorena
Lablytica Life ScienceQPS HoldingsSound BioventuresBioReperia
CyxoneAscelia PharmaFluicellDiamyd Medical
APLSWIPPDevyser DiagnosticsSynthesized pharmaceuticals
AZ BioVentureHubGU VenturesEir Ventures PartnersAbliva
WeQuelMERAccessSahlgrenska Science ParkOrexo
ChancelleryChiesi PharmaceuticalsGalecto BiotechHØIBERG
Spago NanomedicalLINK MedicalAgardh Recruitment & ConsultingContextVision
Prostate Type GenomicsViedocInossiaArcede Pharma
PfizeriCellate MedicalMelius PharmaLIONESS Therapeutics
Abera BioscienceRed Glead DiscoverySARomics BiostructuresOlink Proteomics
Haeger&Carlsson Executive SearchImaGene-iTSpermatozoaKey2Compliance
Empros PharmaBayerBio-Works TechnologiesRidgeview Instruments
Gedea BiotechDosellRegSmart Life ScienceInorbit Therapeutics
Cavis TechnologiesQ&Q Labs (Scantox)Sixera PharmaProbingon
GradientechNanolyzeCAVIDIIndustrial fund
CellcolabsNeogap TherapeuticsKumu Health TechnologiesMedicon Village Innovation
InvivoPowerImmuneedEIP SwedenDevyser
RedoxisSynartroBuzzard PharmaceuticalsCombiGene
AnaMarOne-carbon TherapeuticsBioLaminaAdlersson Heath
BioLaminaImaGene-iTOxcia ABNorthX Biologics
ProPharmaQureTech BioKey2BrainBergman Laboratories
Potter ClarksonCSR InnovationNavinci DiagnosticsBRAVE Recruitment Sweden
TuuLifeScienceResorbable devicesCaptainsAdvanSci Research Solutions
FluicellLokon PharmaEctin ResearchBiovica International
Medical MindsSprint BiosciencePsiloxEXOCURE SWEDEN
Koda consultantGalenometricsSVF VaccinesAlzeCure Pharma
BioArcticSmiLe IncubatorPelago BioscienceCalmino
Sigrid TherapeuticsVERIGRAFTStrike pharmaImmuneed
NYZUAtlas AntibodiesTdB LabsSangair
MicromedicineMedical Innovation DesignInnomed consultantLarodan
DoctrineiCellate MedicalCalmark SwedenProfundus
Beat Vascular HealthCochlearMedfield DiagnosticsMilmed Unico
Nordic BioSiteAdd a MedicalWeQuelPharmista Technologies
Toxicology Knowledge Team SwedenCeffort ControlSepColzyxGrifols Nordic
BIRKA BioStorageEurocine VaccinesMabel AIBiotage
Beactica TherapeuticsLIPUMMetenovacAIre tech
Northernlight DiagnosticsBiosergenDisruptive PharmaPromimic
AAX BiotechAroCellMedivirTruly Labs

Q&A about the Life Science Barometer

What is the purpose of the survey
To promote and strengthen the Swedish life science industry by providing data for informed decisions and international comparisons.

Who should respond?
Top management level in companies and organizations within the life science sector. We also welcome companies supporting the life science sector, such as service providers, investors etc. We use the definition of life sciences as presented in the Swedish life science strategy from 2019, with a focus on supporting human health.

Is the 2023 survey mostly about the pharma pipeline, as the previous year?
No, the 2022 survey had a heavy weight on drug discovery and development. This year, we plan to investigate the industry in a much broader context. Our theme of the year is the current economic climate and the hurdles this brings. Our ambition is to be able to describe the tenacity and growth-oriented mindset prevalent within the Life Science sector, even amid challenging circumstances.

What kinds of questions are there?
The survey is a combination of questions to gather facts as well as opinions and trends. All responses regarding opinions and future outlooks will be kept strictly confidential and only published at an aggregated level, in a way that can be traced to a person and/or a company.

The results from the questions labeled Facts for database will be made publicly available through the database Insight Machine, created and curated by STUNS.

How do we envision the results to be used?
The results from the Barometer will be published in a digital report and presented at the SwedenBIO summit January 30, 2024. The 2023 report will focus on the results from a national perspective, highlighting segments of the industry if the response rates allow.

Following the national report, we plan to create and publish regional reports highlighting regional strengths and focus areas.

We intend to spread the results and key figures from it, through vasious channels to audiences within Sweden and abroad.

What happened with the results from the 2022 Barometer?
The life science Barometer 2022 focused on mapping the Swedish pharma RnD segment for the creation of the 2023 pipeline report. These results have been used and spread around the globe, and attracted interest from eg Politico.